Arrhythmogenic Right Ventricular Cardiomyopathy

• Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe

  2024 European Heart Journal article Medicine Cardiovascular Effects of Exercise Open access

  23

  citations
• Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy

  2023 Science Translational Medicine article Medicine Cardiovascular Effects of Exercise Open access cited by 1 patent

  32

  citations
• Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study

  2022 Circulation article Medicine Cardiovascular Effects of Exercise Open access

  47

  citations
• Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy

  2021 Science Translational Medicine article Medicine Cardiovascular Effects of Exercise Open access cited by 1 patent

  45

  citations
• Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy

  2021 EP Europace article Medicine Cardiovascular Effects of Exercise Open access

  16

  citations
• Stabilization of desmoglein-2 binding rescues arrhythmia in arrhythmogenic cardiomyopathy

  2020 JCI Insight article Medicine Cardiac electrophysiology and arrhythmias Open access cited by 2 patents

  31

  citations
• Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators

  2020 EP Europace article Medicine Cardiovascular Effects of Exercise Open access

  93

  citations

7 results